Bicycle Therapeutics (BCYC)
NASDAQ: BCYC
· Real-Time Price · USD
7.45
0.07 (0.95%)
At close: Aug 15, 2025, 3:59 PM
7.36
-1.21%
After-hours: Aug 15, 2025, 04:10 PM EDT
Bicycle Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.92M | 9.98M | 3.71M | 2.68M | 9.37M | 19.52M | 5.33M | 5.35M | 11.4M | 4.9M | 3.19M | 3.04M | 4.38M | 3.86M | 3.77M | 4.33M | 1.78M | 1.81M |
Cost of Revenue | n/a | 1.64M | 56.07M | 2.19M | 1.64M | 1.66M | 151.59M | 151.61M | 1.65M | 1.57M | 1.4M | 21.41M | 18.29M | 13.49M | 13.9M | 10.12M | 11.34M | 9.69M |
Gross Profit | 2.92M | 9.98M | -52.36M | 481.72K | 7.73M | 17.86M | -146.26M | -146.25M | 9.75M | 3.32M | 1.79M | -18.37M | -13.92M | -9.63M | -10.13M | -5.79M | -9.55M | -7.88M |
Operating Income | -86.6M | -70.2M | -67.66M | -63.85M | -46.65M | -31.72M | -54.23M | -50.8M | -43.11M | -41.8M | -32.21M | -29.76M | -27.3M | -27.38M | -18.02M | -14.29M | -17.28M | -16.02M |
Interest Income | 7.47M | 8.41M | 10.3M | 10.58M | 7.77M | 5.62M | 6.28M | 3.98M | 812K | 2.93M | 2.64M | 1.99M | 908K | 218K | 58K | 24K | 23K | 15K |
Pretax Income | -79.18M | -61.84M | -52.94M | -54.25M | -39.7M | -26.91M | -48.78M | -47.63M | -43.12M | -39.68M | -30.4M | -28.59M | -27.27M | -27.98M | -18.79M | -15.09M | -18.07M | -16.53M |
Net Income | -78.95M | -60.75M | -51.85M | -50.8M | -39.86M | -26.55M | -49.1M | -49.9M | -42.6M | -39.06M | -29.98M | -28.35M | -26.83M | -27.56M | -18.04M | -14.68M | -17.91M | -16.19M |
Selling & General & Admin | 19.24M | 20.92M | 21.02M | 18.26M | 17.71M | 15.13M | 15.05M | 15.57M | 15.18M | 14.49M | 10.68M | 10.25M | 11.82M | 16.85M | 8.84M | 8.27M | 7.35M | 8.14M |
Research & Development | 71.03M | 59.06M | 49.78M | 48.27M | 47.42M | 50.18M | 44.7M | 39.87M | 39.72M | 32.21M | 24.72M | 22.75M | 19.85M | 14.28M | 12.95M | 10.51M | 11.72M | 9.69M |
Other Expenses | -745K | 199K | -55.5M | -45.65M | -3.28M | n/a | -51.34M | -37.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 89.52M | 80.18M | 15.3M | 20.87M | 61.85M | 65.31M | 8.41M | 17.98M | 54.9M | 46.7M | 35.4M | 33M | 31.68M | 31.13M | 21.79M | 18.78M | 19.07M | 17.83M |
Interest Expense | 54K | 51K | 52K | 33K | 824K | 821K | 820K | 814K | 821K | 808K | 826K | 817K | 883K | 818K | 820K | 823K | 819K | 522K |
Selling & Marketing Expenses | n/a | -199K | n/a | n/a | 1.9M | -1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 89.52M | 80.18M | 71.37M | 66.52M | 63.49M | 51.25M | 59.75M | 56.15M | 54.9M | 46.7M | 35.4M | 33M | 31.68M | 31.13M | 21.79M | 18.78M | 19.07M | 17.83M |
Income Tax Expense | -231K | -1.09M | -1.08M | -3.45M | 115K | -15.69M | 320K | 2.27M | -517K | -618K | -420K | -238K | -447K | -419K | -748K | -415K | -160K | -340K |
Shares Outstanding (Basic) | 69.25M | 69.2M | 69.05M | 68.99M | 51.99M | 42.56M | 42.42M | 39.58M | 30.19M | 30M | 29.71M | 29.68M | 29.65M | 29.61M | 28.79M | 25.04M | 24.05M | 22.1M |
Shares Outstanding (Diluted) | 69.25M | 69.2M | 69.05M | 68.99M | 51.99M | 42.56M | 42.42M | 39.58M | 30.19M | 30M | 29.71M | 29.68M | 29.65M | 29.61M | 28.79M | 25.04M | 24.05M | 22.1M |
EPS (Basic) | -1.14 | -0.88 | -0.74 | -0.74 | -0.77 | -0.62 | -1.16 | -1.26 | -1.41 | -1.3 | -1.01 | -0.96 | -0.9 | -0.93 | -0.63 | -0.59 | -0.74 | -0.73 |
EPS (Diluted) | -1.14 | -0.88 | -0.74 | -0.74 | -0.77 | -0.62 | -1.16 | -1.26 | -1.41 | -1.3 | -1.01 | -0.96 | -0.9 | -0.93 | -0.63 | -0.59 | -0.74 | -0.73 |
EBITDA | -77.43M | -70.2M | -65.96M | -61.21M | -37.23M | -39.76M | -52.77M | -49.11M | -41.47M | -40.25M | -30.82M | -28.5M | -26.68M | -26.96M | -17.62M | -13.96M | -16.88M | -15.74M |
EBIT | -79.13M | -61.89M | -67.66M | -63.4M | -18.28M | -5.5M | -54.23M | -50.8M | -43.11M | -38.87M | -29.57M | -27.77M | -27.3M | -27.01M | -17.96M | -14.27M | -17.25M | -16.01M |
Depreciation & Amortization | 1.7M | -8.31M | 1.7M | 2.19M | 1.64M | 1.66M | 1.65M | 1.69M | 1.65M | 1.57M | 1.4M | 1.25M | 611.63K | 419.59K | 407.5K | 335.49K | 339.34K | 326.13K |